There are some accounting concepts in the most recent financial statements released by World Help that warrant discussion. This post will walk through those items I noticed.
This will be a long post. You might want to get a fresh cup of coffee and settle in.
Efforts to reach out to World Help
I have been asking World Help for their comment for a week and a half. The only reply I have received was when the president’s assistant gave me the e-mail contact for the organization’s outside media consultant. I have sent e-mails to the president’s assistant and the contract media consultant several times and received no replies.
Proper accounting is a broader issue in the R&D community than has been discussed
The focus of conversation on accounting in the relief & development community has been variance power and the valuation of medicine, particularly 500 mg mebendazole.
I perceive there are issues involved in disclosures that haven’t yet been discussed.
In accounting shorthand, the matters I see that have not yet been addressed are disclosures of concentration of contributions, concentration of donors, and estimates with a reasonable possibility of change in the near-term.
Posted by Jim Ulvog 